A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY 1142524 in Patients After Acute Myocardial Infarction With Left-ventricular Dysfunction
NCT02976467
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
107
Enrollment
INDUSTRY
Sponsor class
Conditions
Myocardial Infarction
Interventions
DRUG:
Fulacimstat (BAY1142524)
DRUG:
Placebo
Sponsor
Bayer